Now, the work presented at the 2025 annual EULAR congress in Barcelona adds two important pieces to the puzzle.

Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...

Regulatory authorities issued precautionary recommendations following the ORAL Surveillance trial, which demonstrated an ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

Like in the STRIDE study of PAD, GLP-1s improved outcomes, but more work is needed to clarify who may benefit most.

India has officially approved and launched Mounjaro (tirzepatide), a groundbreaking injectable medication for the treatment of Type 2 diabetes and obesity. Developed by Eli Lilly and Company, the drug ...

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), a leader in AI-powered drug discovery and biotherapeutics, today announced ...